Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-021284

Options or other derivatives

  • Chief Medical Officer acquired 107,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Nichols William Garrett Chief Medical Officer 2025-02-12 Grant or award · Stock Option (Right to Buy) +107,250 107,250 D: show line 1 in the form
Loading xslF345X05/ownership.xml…